Copyright
©The Author(s) 2024.
World J Gastroenterol. Sep 7, 2024; 30(33): 3823-3836
Published online Sep 7, 2024. doi: 10.3748/wjg.v30.i33.3823
Published online Sep 7, 2024. doi: 10.3748/wjg.v30.i33.3823
Figure 4 The forest plots for clinicopathological factors in disease-free survival-based multivariate Cox models.
A: The hazard ratios, as well as the 95% confidence intervals and statistical significances, in disease-free survival-based multivariate Cox models for the left-sided colon cancer cohort; B: The hazard ratios, as well as the 95% confidence intervals and statistical significances, in disease-free survival-based multivariate Cox models for the right-sided colon cancer cohort. aP < 0.05; bP < 0.01. LCC: Left-sided colon cancer; RCC: Right-sided colon cancer; DFS: Disease-free survival; PIV: Pan-immune-inflammation value; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; MMR: Mismatch repair; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; SII: Systemic immune-inflammation index.
- Citation: Wang QY, Zhong WT, Xiao Y, Lin GL, Lu JY, Xu L, Zhang GN, Du JF, Wu B. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location. World J Gastroenterol 2024; 30(33): 3823-3836
- URL: https://www.wjgnet.com/1007-9327/full/v30/i33/3823.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i33.3823